NCT07455734
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07455734
Title Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Monash Medical Centre Clayton RECRUITING Clayton 3168 Australia Details
Austin Health NOT_YET_RECRUITING Heidelberg Heights 3081 Australia Details
Peter MacCallum Cancer Centre NOT_YET_RECRUITING Melbourne 3000 Australia Details
Scientia Clinical Research Ltd NOT_YET_RECRUITING Randwick 2031 Australia Details
Epworth HealthCare RECRUITING Richmond 3121 Australia Details
Chongqing University Cancer Hospital RECRUITING Chongqing 400030 China Details
Nanfang Hospital of Southern Medical University RECRUITING Guangzhou 510515 China Details
Zhejiang Cancer Hospital NOT_YET_RECRUITING Hangzhou 310022 China Details
Shanghai East Hospital RECRUITING Shanghai 200120 China Details
Tianjin Medical University Cancer Institute & Hospital RECRUITING Tianjin 300060 China Details
Seoul National University Bundang Hospital NOT_YET_RECRUITING Seongnam 13620 South Korea Details
Seoul National University Hospital NOT_YET_RECRUITING Seoul 3080 South Korea Details
Severance Hospital, Yonsei University Health System NOT_YET_RECRUITING Seoul 3722 South Korea Details
Asan Medical Center NOT_YET_RECRUITING Seoul 5505 South Korea Details
China Medical University Hospital NOT_YET_RECRUITING Taichung 404332 Taiwan Details
National Taiwan University Hospital NOT_YET_RECRUITING Taipei 100225 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field